IDEAYA Biosciences, Inc.
US ˙ NasdaqGS ˙ US45166A1025

SecurityIDYA / IDEAYA Biosciences, Inc.
InstitutionFiera Capital Corp
Latest Disclosed Ownership2,527,076 shares
Latest Disclosed Value $ 84,202,173
Fiera Capital Corp reports 3.69% increase in ownership of IDYA / IDEAYA Biosciences, Inc.

On May 12, 2026 - Fiera Capital Corp filed a 13F-HR form disclosing ownership of 2,527,076 shares of IDEAYA Biosciences, Inc. (US:IDYA) valued at $84,202,172 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,437,262 shares of IDEAYA Biosciences, Inc.. This represents a change in shares of 3.69% during the quarter. The current value of the position is $71,490,980 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F IDEAYA BIOSCIENCES COM 45166A102 2,527,076 89,814 3.69 84,202 -0.06 0.1708
2026-02-11 2025-12-31 13F IDEAYA BIOSCIENCES COM 45166A102 2,437,262 599,295 32.61 84,256 68.47 0.2672
2025-11-07 2025-09-30 13F IDEAYA BIOSCIENCES COM 45166A102 1,837,967 305,698 19.95 50,011 55.28 0.1617
2025-08-08 2025-06-30 13F IDEAYA BIOSCIENCES COM 45166A102 1,532,269 322,404 26.65 32,208 62.53 0.1092
2025-05-07 2025-03-31 13F IDEAYA BIOSCIENCES COM 45166A102 1,209,865 25,398 2.14 19,818 -34.90 0.0716
2025-01-29 2024-12-31 13F IDEAYA BIOSCIENCES COM 45166A102 1,184,467 -105,353 -8.17 30,441 -25.50 0.0959
2024-11-01 2024-09-30 13F IDEAYA BIOSCIENCES COM 45166A102 1,289,820 -45,590 -3.41 40,861 -12.85 0.1229
2024-10-31 2024-06-30 13F/A-2 IDEAYA BIOSCIENCES COM 45166A102 1,335,410 246,010 22.58 46,886 -1.92 0.1453
2024-08-19 2024-06-30 13F/A-1 IDEAYA BIOSCIENCES COM 45166A102 1,335,410 246,010 46,886 0.1467
2024-08-01 2024-06-30 13F IDEAYA BIOSCIENCES COM 45166A102 1,335,410 246,010 46,886 0.0791
2024-08-22 2024-03-31 13F/A-1 IDEAYA BIOSCIENCES COM 45166A102 1,089,400 1,089,400 47,803 0.1393
2024-05-01 2024-03-31 13F IDEAYA BIOSCIENCES COM 45166A102 1,089,400 1,089,400 47,803 0.1393
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.